Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 3978-80-1 | MDL No. : | MFCD00037179 |
Formula : | C14H19NO5 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | - |
M.W : | 281.30 | Pubchem ID : | - |
Synonyms : |
(S)-2-((tert-Butoxycarbonyl)amino)-3-(4-hydroxyphenyl)propanoic acid
|
Chemical Name : | Boc-Tyr-OH |
Num. heavy atoms : | 20 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.43 |
Num. rotatable bonds : | 7 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 3.0 |
Molar Refractivity : | 73.37 |
TPSA : | 95.86 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.09 cm/s |
Log Po/w (iLOGP) : | 1.97 |
Log Po/w (XLOGP3) : | 2.71 |
Log Po/w (WLOGP) : | 1.91 |
Log Po/w (MLOGP) : | 1.42 |
Log Po/w (SILICOS-IT) : | 1.18 |
Consensus Log Po/w : | 1.84 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -3.05 |
Solubility : | 0.25 mg/ml ; 0.000888 mol/l |
Class : | Soluble |
Log S (Ali) : | -4.38 |
Solubility : | 0.0118 mg/ml ; 0.000042 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -2.6 |
Solubility : | 0.71 mg/ml ; 0.00252 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.68 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | With sodium methylate In methanol at 40℃; for 3 h; | Example 2 To a solution of N-Boc-tyrosine (281 mg, 1.0 mmol) in methanol (0.5 mL) were added 28percent sodium methoxide-methanol solution (0.42 mL, 2.1 mmol) and benzyl bromide (162 μL, 1.4 mmol), and the mixture was stirred at 40° C. for 3 hr. Then, water (2 mL) was added to make the system homogeneous, which system was analyzed by HPLC. As a result, the objective N-Boc-(O-benzyl)tyrosine (353 mg, conversion yield 95percent) was confirmed. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
84% | Stage #1: With sodium methylate In methanol at 40℃; for 24 h; Stage #2: With hydrogenchloride In methanol; water |
Example 1 To a solution of N-Boc-tyrosine (281 mg, 1.0 mmol) in methanol (0.5 mL) were added 28percent sodium methoxide-methanol solution (0.42 mL, 2.1 mmol), benzyl chloride (115 μL, 1.4 mmol) and tetrabutylammonium iodide (28 mg) and the mixture was stirred at 40° C. for 24 hr. Then, water (2 mL) was added to make the system homogeneous, which system was then analyzed by HPLC (conversion yield 89percent). The aqueous solution was washed with toluene (0.5 mL), neutralized with hydrochloric acid to allow precipitation of a solid, and the solid was filtered and dried to give the objective N-Boc-(O-benzyl)tyrosine (312 mg, yield 84percent). 1H-NMR (400 MHz, CDCl3)δ: 1.41(s, 3H), 2.86-3.13(m, 2 H), 4.53(m, 1H), 5.01(s, 2H), 6.35-7.41(m, 9H). 13C-NMR (100 MHz, CDCl3)δ: 176.51, 157.99, 136.99, 130.40, 128.58, 127.96, 127.48, 115.00, 80.32, 70.03, 36.93, 28.30. MS(ESI), m/z 370[M+-H] |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | at 20 - 30℃; Inert atmosphere | A mixture of Boc-L-Tyr-OH (5.0 g, 17.8 mmol) in NaOH solution (4M, 10 mL) was treated with second portion of NaOHsolution (4 M, 2 mL) and then dimethyl sulfate (0.9 mL).The reaction temperature was controlled at 20-30 oC by acooling bath. The addition was repeated four times. The reaction was stirred for 2 h atroom temperature after completion of the addition of dimethyl sulfate. The solutionwas acidified with 1 M aq. HCl solution, and then extracted by EtOAc (2×100 mL).The combined organic extracts were washed with brine, dried over Na2SO4, filteredCO2BnNHBocMeOS9and evaporated, giving Boc-Tyr(OMe)-OH as a colorless oil (5.0 g, 95percent yield). |
64% | Stage #1: With sodium hydroxide In acetone at 20 - 35℃; for 2 h; Stage #2: at 0 - 50℃; |
N - tert-butoxycarbonyl - L - tyrosine added to acetone, completely dissolve, keep the reaction system 20 - 35 °C, batch by adding 6 equivalent of sodium hydroxide, after adding stirring 2 hours, maintaining the reaction system 0 - 20 °C, dropwise 3 equivalent of dimethyl sulfate, after adding the room temperature (20 - 30 °C) reaction overnight, water is added to a reaction system, in 40 - 50 °C between evaporating the acetone, acetone after removing, adding ethyl acetate and ice, citric acid solid is acidified to pH=2 - 3, layered, abandoned to the aqueous phase, the oil phase of the saturated salt water for washing three times, sodium sulfate drying 2 hours, filtering to remove sodium sulfate, evaporate most of the ethyl acetate, adding petroleum ether and stirring crystallization, to obtain N - tert butoxycarbonyl - O - methyl - L - tyrosine, yield 64percent. N - tert butoxycarbonyl - O - methyl - L - tyrosine soluble in acetone, maintaining the 10 - 25 °C, slow access after drying of hydrochloric acid gas, reaction 5 hours, insufflating hydrochloric acid gas, cooling to 0 - 10 °C, triethylamine for adjusting pH=7, separate out a large amount of white solid, filtered, and dried to obtain the O - methyl - L - tyrosine, purity 99.5percent, yield 66percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
0.4 g | With lithium aluminium tetrahydride In diethyl etherInert atmosphere; Reflux | N-Boc-L-tyrosinol 4: 1 g of N-Boc-L-tyrosine (3.6 mmol) was dissolved under nitrogen in 80 mL of dry diethyl ether. Then lithium aluminium hydride (0.4 g, 0.01 mol) was added in portions. The suspension was heated to reflux overnight. After cooling to room temperature, ethyl acetate was added and the reaction mixture was poured carefully to concentrated sodium hydroxide solution while stirring. The organic layer was extracted with water and dried with sodium sulphate. 0.4 g oily material was obtained after removing the solvents. 1H NMR (400 MHz, CDCl3): δ 1.37 (9H, s), 2.69 (2H, d, J = 6.51 Hz), 3.47 (1H, dd, J = 5.27, 10.85 Hz), 3.57 (1H, dd, J = 3.75, 10.85 Hz), 3.76 (1H, s), 5.06 (1H, d, J = 7.75 Hz), 6.70 (2H, d, J = 8.37 Hz), 6.97 (2H, d, J = 8.37 Hz), 7.70 (1H, br s) ppm. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
56% | With diphenylphosphoranyl azide; triethylamine In N,N-dimethyl-formamide at 0 - 25℃; for 52h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
0.4 g | With lithium aluminium tetrahydride; In diethyl ether;Inert atmosphere; Reflux; | N-Boc-L-tyrosinol 4: 1?g of N-Boc-L-tyrosine (3.6?mmol) was dissolved under nitrogen in 80?mL of dry diethyl ether. Then lithium aluminium hydride (0.4?g, 0.01?mol) was added in portions. The suspension was heated to reflux overnight. After cooling to room temperature, ethyl acetate was added and the reaction mixture was poured carefully to concentrated sodium hydroxide solution while stirring. The organic layer was extracted with water and dried with sodium sulphate. 0.4?g oily material was obtained after removing the solvents. 1H NMR (400?MHz, CDCl3): delta 1.37 (9H, s), 2.69 (2H, d, J?=?6.51?Hz), 3.47 (1H, dd, J?=?5.27, 10.85?Hz), 3.57 (1H, dd, J?=?3.75, 10.85?Hz), 3.76 (1H, s), 5.06 (1H, d, J?=?7.75?Hz), 6.70 (2H, d, J?=?8.37?Hz), 6.97 (2H, d, J?=?8.37?Hz), 7.70 (1H, br s) ppm. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With sodium hydroxide | |
100% | With sodium hydroxide In 1,4-dioxane; lithium hydroxide monohydrate at 20℃; for 3h; | |
100% | With sodium hydroxide In tetrahydrofuran; lithium hydroxide monohydrate at 20℃; |
100% | With sodium hydroxide In 1,4-dioxane; lithium hydroxide monohydrate Inert atmosphere; | |
100% | With sodium hydroxide In tetrahydrofuran; 1,4-dioxane; lithium hydroxide monohydrate at 25℃; for 3h; | |
97% | With triethylamine In 1,4-dioxane; lithium hydroxide monohydrate at 0℃; for 48h; | |
96.7% | With sodium hydroxide In lithium hydroxide monohydrate; propan-2-one at 20 - 55℃; | 12.1 3-[2-Amino-3-(4-hydroxyphenyl)propanoyl]-3-demethylthiocolchicine was prepared by first tert-butyloxycarbonyl (BOC) protecting L-tyrosine in Stage- 1. L-Tyrosine (10.Og, 0.0552 mol) and 4M sodium hydroxide solution (40.0ml) were charged at RT in a 500 ml three neck round bottomed flask equipped with mechanical stirrer, addition funnel, guard tube, thermo probe and reflux condenser. BOC-anhydride (24.Og, 0.110 mol) dissolved in 30.0ml acetone was added slowly drop wise to the flask at RT. The reaction mass temperature was raised to 50-550C and maintained at this temperature for 6-7 h. The reaction mass was dissolved in demineralized water (250.0ml 25w/v) and cooled to 0-50C. The pH of the reaction mass was adjusted to 2-3 by adding IM potassium hydrogen sulfate and the aqueous layer was extracted with ethyl acetate. The organic layers were washed with demineralized water followed by brine. The resulting organic layer was dried over sodium sulphate and concentrated to 15 g of white solid (96.7% yield). |
95% | With sodium hydroxide In 1,4-dioxane; lithium hydroxide monohydrate at 25℃; for 6h; | |
94% | With sodium hydroxide In 1,4-dioxane; lithium hydroxide monohydrate at 0 - 20℃; for 72h; Inert atmosphere; | |
94% | With potassium carbonate In 1,4-dioxane; lithium hydroxide monohydrate at 20℃; | |
94% | With sodium hydroxide In 1,4-dioxane; lithium hydroxide monohydrate at 0 - 20℃; for 6h; | |
92% | With triethylamine In 1,4-dioxane; lithium hydroxide monohydrate for 18h; Ambient temperature; | |
92% | With potassium hydroxide In 1,4-dioxane; lithium hydroxide monohydrate at 20℃; for 6h; | |
92% | Stage #1: di-<i>tert</i>-butyl dicarbonate; tyrosine With sodium hydroxide In 1,4-dioxane at 20℃; for 14h; Stage #2: With hydrogenchloride; lithium hydroxide monohydrate In dichloromethane | |
92% | With triethylamine In 1,4-dioxane; lithium hydroxide monohydrate at 0 - 20℃; for 18.5h; | |
92% | With triethylamine In 1,4-dioxane; lithium hydroxide monohydrate | |
92% | With trimethylamine In tetrahydrofuran; lithium hydroxide monohydrate at 0 - 25℃; | |
91% | With triethylamine In 1,4-dioxane; lithium hydroxide monohydrate at 20℃; | |
90% | With triethylamine In 1,4-dioxane; lithium hydroxide monohydrate at 0 - 20℃; for 21h; | |
90% | With sodium hydroxide In 1,4-dioxane; lithium hydroxide monohydrate at 20℃; for 2h; Inert atmosphere; | 4 4.4 .Nα-[tert-butoxycarbonyl]-L-tyrosine (6) L-Tyrosine (2 g, 11 mmol) was dissolved in a mixture of dioxane/water (50 mL/25 mL), followed by the addition of 25 mL of NaOH (1 M). Di-tert-butyl dicarbonate (2.64 g, 12.1 mmol) was then added and the reaction mixture was allowed to stir at room temperature for 2 h. The reaction mixture was extracted by EtOAc (3 * 20 mL). The combined extraction was dried over Na2SO4. After removing the solvent by rotary evaporation, the compound 6 was obtained as a white solid (3 g, 10 mmol, 90%). 1H NMR (300 MHz, CDCl3): δ 7.10 (d, J = 8.3 Hz, 2H), 6.71 (d, J = 8.4 Hz, 2H), 5.25 (d, J = 6.9 Hz, 1H), 4.52 (s, 1H, OH), 4.32-4.30 (m, 1H), 3.00-2.96 (m, 2H), 1.38 (s, 9H). |
90% | With sodium hydroxide In 1,4-dioxane; lithium hydroxide monohydrate at 0℃; | |
90% | With anhydrous sodium carbonate In 1,4-dioxane; lithium hydroxide monohydrate at 0 - 25℃; for 16h; | 7.1 Step 1: Synthesis of (S) -2- ( (tert-butoxycarbonyl) amino) -3- (4-hydroxyphenyl) propanoic acid (122) To a solution of compound 121 (2.0 g, 11.0 mmol) in dioxane/H2O (20/10 mL) was added Na2CO3(3.5 g, 33.0 mmol) and Boc2O (3.5 g, 16.5 mmol) at 0 . The reaction mixture was allowed to warm to 25 and stirred for 16 h and then was removed under vacuum. Water (20 mL) was added to the mixture, and extracted by EA (10 mL) . The water layer was added HCl (4M in water) until pH2-3 and extracted by EA (3×10 mL) . The combined organic layer was washed with aqueous brine (20 mL) , dried over Na2SO4and concentrated in vacuum to give the titled product 122 (2.8 g, 90) as a yellow solid.[0523]MS (ESI) : [M+H+] 281.9. |
89% | With N-ethyl-N,N-diisopropylamine; sodium hydroxide In 1,4-dioxane; lithium hydroxide monohydrate at 20℃; for 3h; | |
86.56% | With sodium hydroxide In 1,4-dioxane; lithium hydroxide monohydrate at 20℃; for 6h; | |
85% | Stage #1: di-<i>tert</i>-butyl dicarbonate; tyrosine With sodium hydroxide In 1,4-dioxane; lithium hydroxide monohydrate at 20℃; for 4h; Stage #2: With sulfuric acid potassium salt In 1,4-dioxane; lithium hydroxide monohydrate; ethyl acetate | |
84% | Stage #1: tyrosine With sodium hydroxide In 1,4-dioxane; lithium hydroxide monohydrate Stage #2: di-<i>tert</i>-butyl dicarbonate In 1,4-dioxane; lithium hydroxide monohydrate at 20℃; for 7h; | 4 4.2.4. N-Boc-L-tyrosinol-silane precursor 10 N-Boc-L-tyrosine. The L-tyrosine protection was performed followinga reported procedure62 with some modifications. 10 g (0.06 mol) of l-tyrosine were stirred in 250 ml dioxane and water mixture (1:1) and 75 mL of 1 M sodium hydroxide solution was added until all the solid dissolved. After cooling the solution in an ice bath, 12 g (0.06 mol) of di-tert-butyl dicarbonate was added. After stirring for 7 h in room temperature, the reaction was concentrated by reducing pressure followed by addition of 50 mL of ethyl acetate and a concentrated potassium hydrogen sulphate solution until the pH reached 2. Then the aqueous phase was extracted twice with ethyl acetate and the combined organic phases were dried with sodium sulphate. After removing the solvent under reduced pressure a 13 g (84% yield) of pinkish solid were obtained. 1H NMR (400 MHz, DMSO-d6): δ 1.31 (9H, s), 2.67 (1H, dd, J = 9.90, 13.85 Hz), 2.86 (1H, dd, J = 4.95, 13.85 Hz), 3.92-4.02 (1H, m), 6.63 (2H, d, J = 7.73 Hz), 7.01 (2H, d, J = 7.73 Hz), 9.18 (1H, s), 12.5 (1H, br s) ppm. |
81% | Stage #1: di-<i>tert</i>-butyl dicarbonate; tyrosine With sodium hydroxide In tetrahydrofuran; lithium hydroxide monohydrate at 0 - 20℃; for 20.6667h; Stage #2: With hydrogenchloride In lithium hydroxide monohydrate | |
81% | In dichloromethane at 20℃; for 20h; | |
80% | With sodium hydroxide In 1,4-dioxane at 20℃; for 6h; | |
75% | With sodium hydroxide In lithium hydroxide monohydrate; <i>tert</i>-butyl alcohol at 20℃; | |
75% | With sodium hydroxide In lithium hydroxide monohydrate; <i>tert</i>-butyl alcohol at 20 - 40℃; for 24h; | |
73% | With sodium hydroxide In 1,4-dioxane; lithium hydroxide monohydrate at 20℃; for 18h; | |
66% | With triethylamine In 1,4-dioxane; lithium hydroxide monohydrate at 20℃; | |
61.2% | With sodium hydroxide In isopropanol Ambient temperature; | |
60% | With sodium hydroxide In 1,4-dioxane at 25℃; for 1h; | |
With sodium hydroxide In lithium hydroxide monohydrate; <i>tert</i>-butyl alcohol | ||
With sodium hydroxide; Sodium hydrogenocarbonate In 1,4-dioxane at 0 - 20℃; | ||
9.8 g | With triethylamine In 1,4-dioxane; lithium hydroxide monohydrate 0 deg C, 30 min; 25 deg C, 24 h; | |
With Sodium hydrogenocarbonate In tetrahydrofuran at 23℃; for 12h; | ||
With 1-ethyl-2,2,4,4,4-pentakis(dimethylamino)-2λ5,4λ5-catenadi(phosphazene) In acetonitrile at 20℃; for 16h; | ||
With sodium hydroxide In 1,4-dioxane at 20℃; | ||
With hydrogenchloride; triethylamine In 1,4-dioxane; lithium hydroxide monohydrate; ethyl acetate | 1 N-t-butoxycarbonyl-L-tyrosine (II) Example 1 N-t-butoxycarbonyl-L-tyrosine (II) L-Tyrosine (I, 9.06 g, 50 mmol) is suspended in dioxane/water (1/1, 180 ml). Triethylamine (10.45 ml, 75 mmol) is added. The reaction mixture is cooled to -10° and di-tert-butyl dicarbonate (12.0 g, 55 mmol) is added. After 1 hr at -10°, the reaction is warmed to 20-25°e. The suspension is stirred at 20-25° for 18 hr. The resulting mixture is concentrated and then partitioned in ethyl acetate (90 ml) and water (45 ml). The aqueous phase is collected and adjusted to pH 1 using hydrochloric acid (1 M). The aqueous mixture is extracted with ethyl acetate (180 ml). The extract is dried over magnesium sulfate, filtered and concentrated to give the title compound, NMR (DMSO-d6) δ 9.15, 7.01, 6.95, 6.64, 3.98, 2.86, 2.68 and 1.32; CMR (DMSO-d6) δ 174.1, 156.2, 155.8, 130.3, 128.3, 115.3, 78.4, 55.8, 36.0 and 28.5; MS (CI, NH3) m/z (relative intensity) 299, 282, 243, 226, 182 and 124. | |
With anhydrous sodium carbonate In tetrahydrofuran; lithium hydroxide monohydrate at 0 - 20℃; | ||
With triethylamine In 1,4-dioxane; lithium hydroxide monohydrate at 0 - 20℃; | ||
With sodium hydroxide In 1,4-dioxane; lithium hydroxide monohydrate at 20℃; for 20h; | VII.a To a solution of Tyrosine in 2M NaOH was added a solution of di-t-butyl pyrocarbonate in dioxane and the mixture was stirred at room temperature for about 20 hrs. Dioxane was removed from the reaction mixture. The aqueous solution was acidified with 10% KHSO4 solution and the liberated Boc-Tyr was extracted into ethyl acetate. The ethyl acetate solution was washed with water, dried and concentrated. Precipitation was done using petroleum ether (60-800). | |
Stage #1: di-<i>tert</i>-butyl dicarbonate; tyrosine With sodium hydroxide In tetrahydrofuran; lithium hydroxide monohydrate at 20℃; for 6h; Stage #2: With citric acid In lithium hydroxide monohydrate | 5.1.1. (S)-7-(Tert-butoxycarbonyl)-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid (2) General procedure: To a solution of compound 1 (5.72 g, 20.0 mmol) in 44 mL of 1 N NaOH, was added a solution of (Boc)2O (4.80 g, 22.0 mmol) in THF (10 mL). The solution was kept between pH 9-11 by addition of 1 N NaOH. After stirring the mixture at room temperature for 6 h, THF was evaporated in vacuum with the residues being adjusted to pH 4-5 with 1 N aqueous citric acid. Then the mixture was extracted with EtOAc (3 × 25 mL). The extractions were combined, washed with brine (3 × 20 mL), dried over MgSO4 and evaporated to give 5.80 g of crude product compound 2 as a light brown solid. This product was used for the following reaction without further purification. | |
5.3 g | Stage #1: di-<i>tert</i>-butyl dicarbonate; tyrosine With sodium hydroxide In tetrahydrofuran at 20℃; for 8h; Stage #2: With lithium hydroxide monohydrate; citric acid | 5.1.1. (S)-2-((tert-Butoxycarbonyl)amino)-3-(4-hydroxyphenyl)propanoic acid (B) To a solution of compound A (3.62 g, 20.0 mmol) in 44 mL of 1 N NaOH, was added a solution of (Boc)2O (4.80 g, 22.0 mmol) in THF (10 mL). The solution was kept between pH 9 and 11 by addition of 1 N NaOH. After stirring the mixture at room temperature for 8 h, THF was evaporated in vacuum with the residues being adjusted to pH 4-5 with 1 N aqueous citric acid. Then the mixture was extracted with EtOAc (3 × 25 mL). The extractions were combined, washed with brine (3 × 20 mL), dried over MgSO4 and evaporated to give 5.30 g of crude product compound B as a white solid. This product was used for the following reaction without further purification. ESI-MS m/z: 282.1 [M+H]+. |
With sodium hydroxide In methanol | ||
With triethylamine In methanol for 3h; Reflux; | General procedure: To a solution of amino acids 1a-j (20 mmol) in methanol (90 mL) was added di-tert-butyl carbonate (8.73 g, 40 mmol) and triethylamine (11.1 mL, 80 mmol). The reaction mixture was heated to refluxing and stirred for 3 h at the same temperature, and concentrated under reduced pressure. The residue was diluted with water (40 mL), adjusted to pH 2.0-3.0 with 2 N HCl at 0-5 °C, and then extracted with ethyl acetate (50 mL × 3). The combined extracts were washed with saturated brine (30 mL), dried over anhydrous Na2SO4, and then concentrated under reduced pressure to provide 2a-j as white solids [18-23] (64.8%-91.4%). A mixture of IMB-070593 (2.08 g, 4.97 mmol), 2a-j (5.71 mmol), dicyclohexylcarbodiimide (1.18 g, 5.71 mmol) and dry dichloromethane (42 mL) was stirred at room temperature for 1 h and filtered. The filtrate was concentrated under reduced pressure, and the residue was treated with diethyl ether (20 mL), and then filtered. The solid was purified by column chromatography (silica gel) eluted with dichloromethane and methanol (v:v = 55:1) to afford the title compounds 3a-j (36%-79%, from 1a-j) as white or yellow solids. | |
With triethylamine In 1,4-dioxane at 20℃; | ||
With triethylamine In 1,4-dioxane; lithium hydroxide monohydrate at 0 - 20℃; for 25h; | ||
With sodium hydroxide In 1,4-dioxane; lithium hydroxide monohydrate at 0℃; for 2h; | ||
With sodium hydroxide In 1,4-dioxane; lithium hydroxide monohydrate at 0 - 20℃; | 4.1. General procedures for the synthesis of N-protected phenylalanine and tyrosine amide 1 and dipeptides 3, 5 General procedure: Chloroformate (benzyl chloroformate) or acid anhydride ((Boc)2O) (1.2 equiv.) was added dropwise to a solution of phenylalanine or tyrosine in 0.5 Maq. NaOH:1,4-dioxane = 1:1 at 0 °C. The mixture was stirred overnight at room temperature, and evaporated to remove 1,4-dioxane. The aqueous solution was acidified by the slow addition of 1M HCl until the pH decreased to 3 and then extracted with EtOAc. The organic layer was dried over Na2SO4 and concentrated in vacuo. The crude product was recrystallized by hexane/EtOAc to give the corresponding N-protected phenylalanine and tyrosine (70-80%). | |
With triethylamine In 1,4-dioxane; lithium hydroxide monohydrate at 20℃; for 10h; | 23.23.1 23.1, (Intermediate 10) L-Tyrosine (10 g, 55.2 mmol) was dissolved in 300 mL1,4-dioxane and water (v / v 1: 1),Triethylamine (11.2 g, 110.7 mmol) and then were added at room temperatureDi-tert-butyl dicarbonate (13.3 g, 60.9 mmol), stirred at room temperature for 10 hours,TLC monitoring reaction is completed. 1,4-dioxane was distilled off under reduced pressure,And add 500mL dichloromethane,2N aqueous hydrochloric acid was added dropwise to the aqueous layer with stirring at about pH 5,The organic layer was separated and washed once with 200 mL of saturated brine,Dried over anhydrous magnesium sulfate, filtered and the solvent evaporated to dryness under reduced pressure to give the crude product,The yield was 99% and the next reaction was carried out without further purification. | |
With triethylamine In 1,4-dioxane; lithium hydroxide monohydrate at 20℃; for 10h; | 23.1 L-Tyrosine (10 g, 55.2 mmol) was dissolved in a mixed solution of 300 mL of 1,4-dioxane and water (v / v 1:1) Triethylamine (11.2 g, 110.7 mmol) and di-tert-butyl dicarbonate (13.3 g, 60.9 mmol) were sequentially added at room temperature and the mixture was stirred at room temperature for 10 hours. The reaction was completed by TLC. 1,4-dioxane was evaporated under reduced pressure and 500 mL of methylene chloride was added. 2N aqueous hydrochloric acid was added dropwise to the aqueous layer with stirring at a pH of about 5. The organic layer was separated and washed once with 200 mL of saturated brine, Drying over magnesium sulfate, filtration and evaporation of the solvent under reduced pressure gave a crude product in 99% yield, which was carried on to the next reaction without further purification. | |
In 1,4-dioxane; lithium hydroxide monohydrate at 20℃; for 18h; Cooling with ice; | 1 3d: L-tyrosine (30.00 g, 0.17 mol), water (300 mL) was added in turn to a 2000 mL round bottom flask.1,4-dioxane (300 mL), triethylamine (35 mL, 248.40 mmol), ice bath,Di-tert-butyl dicarbonate (41.70 mL, 182.40 mmol) was added, stirred for 30 min and allowed to react at room temperature for 18 h.Desolvation, solids were diluted with water, ethyl acetate, pH adjusted to 1 with dilute hydrochloric acid, extracted with ethyl acetate,The organic phase was washed with saturated sodium bicarbonate solution, saturated sodium chloride solution, dried over anhydrous sodium sulfate, and suction-filtered., Desolvation, light yellow transparent oil, plus some Boc anhydride, without further purification directly to the next step.In a 2000 mL round-bottom flask, N-Boc-L-tyrosine generated in the previous step (theory 0.16 mol), N,N-dimethylformamide (890 mL), potassium carbonate (114 g, 0.83 mol), tetrabutylammonium iodide (7.6 g, 0.02 mol),Benzyl bromide (59 mL, 0.49 mol) was reacted at room temperature for 48 h. Water (900 mL) was added and extracted with ethyl acetate (600 mL*3).The organic phases were combined, dried over anhydrous sodium sulfate, suction filtered, desolved, and directly cast to the next step.In a 2000 mL round-bottomed flask, N-Boc-O-benzyl-L-tyrosine benzyl ester (theory 0.16 mol) generated in the previous step was added (500 mL).1,4-dioxane (500 mL) was added sodium hydroxide (22.00 g, 0.55 mol) and stirred at room temperature for 24 h.The 1,4-dioxane was partially removed by dissolving, washed with an appropriate amount of ether, and the aqueous phase was acidified with dilute hydrochloric acid and extracted three times with ethyl acetate.Combine the organic phases, dry over anhydrous sodium sulfate, remove with suction and filter to give a yellow oil, with ethanol,The petroleum ether is recrystallized to give 63.25 g of a white solid, 61.55 g of theory, and some of the solvents are added. The three-step yield is greater than 99%. | |
With triethylamine In 1,4-dioxane; lithium hydroxide monohydrate at 0 - 80℃; for 96h; Inert atmosphere; | (S)-2-(tert-butoxycarbonylamino)-3-(4-hydroxyphenyl)propanoic acid (14) To a mixture of L-tyrosine 13 (0.91 g, 5.03 mmol) and Et3N (1.52 mL, 11.0 mmol) in 50% 1,4-Dioxane/water (100 mL) was added dropwise (Boc)2O (1.52 mL, 11.0 mmol) at 0 °C under N2 atmosphere. After 24 h, the temperature was raised from 0 °C to 80 °C for another 72 h. The mixture was filtered and the concentrated residue was redissolved in EtOAc (100 mL) which was washed with saturated brine (100 mL × 3), dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified by flash silica gel column chromatography [petroleum ether-EtOAc = (4:1), V/V] to give the corresponding target product as a solid (1.28 g, 91%). HPLC analysis: 92.5%. 1H-NMR (400 MHz, MeOD): 1.29 (s, 9H), 2.71 (dd, J = 13.8, 8.8 Hz, 1H), 2.94 (dd, J = 13.8, 4.9 Hz, 1H), 4.16-4.19 (m, 1H), 6.60 (d, J = 8.2 Hz, 2H), 6.93 (d, J = 8.2 Hz, 2H). 13C-NMR (100 MHz, MeOD): 174.2, 156.4, 155.8, 129.9, 127.8, 114.7, 79.1, 55.1, 36.5, 27.3. ESI-MS m/z: 282.1 (M+H)+. | |
With sodium hydroxide In 1,4-dioxane; lithium hydroxide monohydrate at 20℃; | ||
With sodium hydroxide In 1,4-dioxane; lithium hydroxide monohydrate at 0 - 20℃; for 3h; | General procedure for the synthesis of N4 amino acid-acylated nucleosides 4a-h General procedure: Appropriate amino acid 1a-h (6.66 mmol) was dissolved in 24 mL of 1,4-dioxane and water mixture (1:1), 13.3 mL of 1 N NaOH (2 mol. eq.) was slowly added and the mixture was chilled in the freezer for 20 min. Di-tert-butyl dicarbonate (10 mmol) was added and the mixture was stirred for 3 hours at room temperature. The reaction was monitored by TLC analysis. After the reaction was completed, the solvent mixture was concentrated to 2-5 mL using a rotary evaporator and aqueous solution of citric acid (10%) was added until pH reached 2.0. The mixture was extracted with ethyl acetate. The organic phase was dried with anhydrous sodium sulphate and evaporated under reduced pressure to recover Boc-protected amino acid 2a-h. The protected amino acid 2a-h was dissolved in 30 mL of ethyl acetate, 7.33 mmol of N-hydroxysuccinimide and 7.33 mmol of N,N'-dicyclohexylcarbodiimide were added and the reaction mixture was stirred for 24 hours at room temperature. The formed white precipitate was filtered, ethyl acetate was removed under reduced pressure to obtain N-Boc protected and NHS-activated amino acid 3a-h. The protected-activated acid was dissolved in dimethylformamide (8-10 mL) and 2'-deoxycytidine (6.66 mmol) was added. The reaction mixture was stirred for 5 days at room temperature. After the reaction was completed, dimethylformamide was removed using a rotary evaporator and the residue was purified by column chromatography (silica gel, chloroform/methanol mixture, 100:0→85:15). The products were obtained in 34-85% yields. Synthesized nucleosides were characterized by NMR spectroscopy and HPLC-MS analysis. | |
With triethylamine In 1,4-dioxane; lithium hydroxide monohydrate for 12h; Reflux; | ||
With sodium hydroxide In 1,4-dioxane; lithium hydroxide monohydrate | ||
With sodium hydroxide In 1,4-dioxane at 0 - 20℃; Inert atmosphere; | 2.2.1. (tert-butoxycarbonyl)-L-phenylalanine (c1), (tert-butoxycarbonyl)-D-phenylalanine (c5), (tert-butoxy-carbonyl)-L-tyrosine (c7) and (tert-butoxycarbonyl)-L-tryptophan (c8): General procedure 1 General procedure: Required amino acid (30 mmol, 1 equiv) was taken in 1,4-dioxane (40 mL) as a solvent and stirred at 0°C to get a clear solution. 1M sodium hydroxide (NaOH) solution (20 mL) was added to the reaction mixture, followed by Boc anhydride (36 mmol, 1.2 equiv). After half an hour, the milky white or hazy solution was obtained, which was further stirred overnight. Upon completion of the reaction, the mixture was acidified to pH 4 using dilute HCl (Hydrochloric acid) and extracted by ethyl acetate (50 mL *3). This organic layer was dried over sodium sulfate and distilled under reduced pressure to obtain the product as a semi-solid paste (except for c5, which was obtained as an off-white solid); yield was approximately 90 to 95%. | |
With sodium hydroxide In 1,4-dioxane at 0 - 20℃; Inert atmosphere; | 2.2.1. (tert-butoxycarbonyl)-L-phenylalanine (c1), (tert-butoxycarbonyl)-D-phenylalanine (c5), (tert-butoxy-carbonyl)-L-tyrosine (c7) and (tert-butoxycarbonyl)-L-tryptophan (c8): General procedure 1 General procedure: Required amino acid (30 mmol, 1 equiv) was taken in 1,4-dioxane (40 mL) as a solvent and stirred at 0°C to get a clear solution. 1M sodium hydroxide (NaOH) solution (20 mL) was added to the reaction mixture, followed by Boc anhydride (36 mmol, 1.2 equiv). After half an hour, the milky white or hazy solution was obtained, which was further stirred overnight. Upon completion of the reaction, the mixture was acidified to pH 4 using dilute HCl (Hydrochloric acid) and extracted by ethyl acetate (50 mL *3). This organic layer was dried over sodium sulfate and distilled under reduced pressure to obtain the product as a semi-solid paste (except for c5, which was obtained as an off-white solid); yield was approximately 90 to 95%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | With sodium hydroxide; at 20 - 30℃;Inert atmosphere; | A mixture of Boc-L-Tyr-OH (5.0 g, 17.8 mmol) in NaOH solution (4M, 10 mL) was treated with second portion of NaOHsolution (4 M, 2 mL) and then dimethyl sulfate (0.9 mL).The reaction temperature was controlled at 20-30 oC by acooling bath. The addition was repeated four times. The reaction was stirred for 2 h atroom temperature after completion of the addition of dimethyl sulfate. The solutionwas acidified with 1 M aq. HCl solution, and then extracted by EtOAc (2×100 mL).The combined organic extracts were washed with brine, dried over Na2SO4, filteredCO2BnNHBocMeOS9and evaporated, giving Boc-Tyr(OMe)-OH as a colorless oil (5.0 g, 95% yield). |
64% | N - tert-butoxycarbonyl - L - tyrosine added to acetone, completely dissolve, keep the reaction system 20 - 35 C, batch by adding 6 equivalent of sodium hydroxide, after adding stirring 2 hours, maintaining the reaction system 0 - 20 C, dropwise 3 equivalent of dimethyl sulfate, after adding the room temperature (20 - 30 C) reaction overnight, water is added to a reaction system, in 40 - 50 C between evaporating the acetone, acetone after removing, adding ethyl acetate and ice, citric acid solid is acidified to pH=2 - 3, layered, abandoned to the aqueous phase, the oil phase of the saturated salt water for washing three times, sodium sulfate drying 2 hours, filtering to remove sodium sulfate, evaporate most of the ethyl acetate, adding petroleum ether and stirring crystallization, to obtain N - tert butoxycarbonyl - O - methyl - L - tyrosine, yield 64%. N - tert butoxycarbonyl - O - methyl - L - tyrosine soluble in acetone, maintaining the 10 - 25 C, slow access after drying of hydrochloric acid gas, reaction 5 hours, insufflating hydrochloric acid gas, cooling to 0 - 10 C, triethylamine for adjusting pH=7, separate out a large amount of white solid, filtered, and dried to obtain the O - methyl - L - tyrosine, purity 99.5%, yield 66%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
81% | Stage #1: Boc-Tyr-OH With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide; toluene for 0.75h; Cooling with ice; Stage #2: 1-aminooctadecane In N,N-dimethyl-formamide; toluene at 60℃; for 22h; | |
With 1-hydroxy-pyrrolidine-2,5-dione; dicyclohexyl-carbodiimide In chloroform at 0℃; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
13% | With potassium carbonate; In N,N-dimethyl-formamide; at 20℃; | L - tyrosine (2.8 g, 10 mmol) was dissolved in 50 mL DMF, then K2CO3(4.15 g, 30 mmol) and iodomethane (1.37 mL, 22 mmol) were added in a row. Stirred at room temperature till the reactant was run out, detected by TLC. Then, 150 mL water was added into the solution and extracted with EtOAc. After dried by MgSO4 and concentrated, the obtained oil was dissolved in 30 mL methanol and NaOH (1.3 mmol/mL) was added. After stirred for 5 h, the solution was neutralized by 1M HCl solution and extracted with EtOAc. 0.5M citric acid and brine were used to wash the organic phase, and concentrated to colorless oil. Finally, purification by column chromatography (PE/EA=10: 3) to generate compound 6a, colorless oil. Yield: 13%. 1H NMR (400 MHz,Chloroform-d) delta 7.12 (d, J=8.2 Hz, 2H), 6.87 (d, J=8.4 Hz, 2H), 4.68- 4.49 (m, 1H), 3.81 (s, 3H), 3.11 (ddd, J=34.8, 13.6, 5.3 Hz, 2H),1.45 (s, 9H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
97% | With potassium hydroxide In N,N-dimethyl-formamide at 25℃; for 3.5h; | |
91% | With potassium carbonate In water; N,N-dimethyl-formamide for 2h; Ambient temperature; | |
89% | With potassium carbonate In N,N-dimethyl-formamide at 20℃; Cooling with ice; | 23.23.2 23.2, (Intermediate 11) Intermediate 10 (7.7 g, 27.4 mmol) was dissolved in 100 mLN, N-dimethylformamide, stirred for 10 minutes in an ice bath,Potassium carbonate (8.3 g, 60.1 mmol) and methyl iodide were added successively(7.8 g, 55.0 mmol), stirred in an ice bath for 30 minutes,Stir overnight at room temperature. The reaction mixture was poured into 300 mL of ethyl acetate, washed twice with water (300 mL * 2) and once with saturated brine (100 mL *1), dried over anhydrous sodium sulfate, filtered and the solvent evaporated to give the crude product, which was purified by column chromatography to give the title product in 89% |
89% | With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.5h; Cooling with ice; | 23.2 Intermediate 10 (7.7 g, 27.4 mmol) was dissolved in 100 mL of N, N-dimethylformamide and stirred for 10 minutes in an ice bathPotassium carbonate (8.3 g, 60.1 mmol) and methyl iodide (7.8 g, 55.0 mmol) were sequentially added and the mixture was stirred for 30 minutes in an ice bath and stirred at room temperature overnight. The reaction mixture was poured into 300 mL of ethyl acetate, washed twice with water (300 mL * 2), once with saturated brine (100 mL * 1), dried over anhydrous sodium sulfate, filtered and the solvent evaporated to give crude product. Purified the target product, the yield of 89% |
74% | With potassium hydroxide In N,N-dimethyl-formamide at 20℃; for 3.5h; | |
74% | With potassium hydroxide In DMF (N,N-dimethyl-formamide) at 0 - 20℃; for 3.41667h; | (2S)-tert-Butoxycarbonylamino-3- (4-methoxy-phenyl)-propionic acid methyl ester;: A solution of (2S)-tert-Butoxycarbonylamino-3- (4-hydroxy-phenyl)-propionic acid (8.00 g, 28.5 mmol) in dimethylformamide (80 mi) was treated with ground potassium hydroxide (1.72 g, 31.3 mmol) and iodomethane (1.95 ml, 31.3 mmol) (in 20 ml dimethylformamide) was added dropwise over 5 min at 0°C. The reaction was stirred at room temperature for 30 min and, after this time period, additional ground potassium hydroxide (1.72 g, 31.3 mmol) and iodomethane (1.95 ml, 31.3 mmol) (in 20 ml dimethylformamide) were added at 0°C. The reaction was then left to stir for 3 h. The solution was poured onto ice (150 ml) and extracted with ethyl acetate (3 x 75 ml). The organic layers were washed with water (3 x 50 ml), brine (2 x 50 ml) and dried (MgSO4). The solvent was removed under reduced pressure to yield a colourless oil. Crystallization was achieved from ethyl acetate/light petroleum, to give colourless crystals (6.5 g, 74%); m. p. 52-53 °C ; m/z 309; C16H23NO5 requires 309.15762. |
74% | With potassium hydroxide In N,N-dimethyl-formamide at 0 - 20℃; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 5 steps 1: 60 percent / DCC / acetonitrile / -10 °C 2: 36 percent / hydrazine hydrate / methanol / Ambient temperature 3: isopentyl nitrite 4: 53 percent / dimethylformamide / 4 °C 5: 79 percent / anisole, trifluoroacetic acid / 1 h / Ambient temperature | ||
Multi-step reaction with 5 steps 1: 72 percent / 1-hydroxybenzotriazol, dicyclohexylcarbodiimide / dimethylformamide / 1 h / 0 °C 2: hydrogen / palladium black / 2-methyl-propan-2-ol / 8 h 3: dicyclohexylcarbodiimide / CHCl3 / 3 h / -20 - 0 °C / r.t., overnight 4: 86 percent / hydrogen / palladium black / 2-methyl-propan-2-ol / 16 h 5: trifluoroacetic acid |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | With sodium methylate;tetra-(n-butyl)ammonium iodide; In methanol; at 40℃; for 3h; | Example 2 To a solution of N-Boc-tyrosine (281 mg, 1.0 mmol) in methanol (0.5 mL) were added 28% sodium methoxide-methanol solution (0.42 mL, 2.1 mmol) and benzyl bromide (162 muL, 1.4 mmol), and the mixture was stirred at 40 C. for 3 hr. Then, water (2 mL) was added to make the system homogeneous, which system was analyzed by HPLC. As a result, the objective N-Boc-(O-benzyl)tyrosine (353 mg, conversion yield 95%) was confirmed. |
3d: L-tyrosine (30.00 g, 0.17 mol), water (300 mL) was added in turn to a 2000 mL round bottom flask.1,4-dioxane (300 mL), triethylamine (35 mL, 248.40 mmol), ice bath,Di-tert-butyl dicarbonate (41.70 mL, 182.40 mmol) was added, stirred for 30 min and allowed to react at room temperature for 18 h.Desolvation, solids were diluted with water, ethyl acetate, pH adjusted to 1 with dilute hydrochloric acid, extracted with ethyl acetate,The organic phase was washed with saturated sodium bicarbonate solution, saturated sodium chloride solution, dried over anhydrous sodium sulfate, and suction-filtered., Desolvation, light yellow transparent oil, plus some Boc anhydride, without further purification directly to the next step.In a 2000 mL round-bottom flask, N-Boc-L-tyrosine generated in the previous step (theory 0.16 mol), N,N-dimethylformamide (890 mL), potassium carbonate (114 g, 0.83 mol), tetrabutylammonium iodide (7.6 g, 0.02 mol),Benzyl bromide (59 mL, 0.49 mol) was reacted at room temperature for 48 h. Water (900 mL) was added and extracted with ethyl acetate (600 mL*3).The organic phases were combined, dried over anhydrous sodium sulfate, suction filtered, desolved, and directly cast to the next step.In a 2000 mL round-bottomed flask, N-Boc-O-benzyl-L-tyrosine benzyl ester (theory 0.16 mol) generated in the previous step was added (500 mL).1,4-dioxane (500 mL) was added sodium hydroxide (22.00 g, 0.55 mol) and stirred at room temperature for 24 h.The 1,4-dioxane was partially removed by dissolving, washed with an appropriate amount of ether, and the aqueous phase was acidified with dilute hydrochloric acid and extracted three times with ethyl acetate.Combine the organic phases, dry over anhydrous sodium sulfate, remove with suction and filter to give a yellow oil, with ethanol,The petroleum ether is recrystallized to give 63.25 g of a white solid, 61.55 g of theory, and some of the solvents are added. The three-step yield is greater than 99%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
84% | Example 1 To a solution of N-Boc-tyrosine (281 mg, 1.0 mmol) in methanol (0.5 mL) were added 28% sodium methoxide-methanol solution (0.42 mL, 2.1 mmol), benzyl chloride (115 muL, 1.4 mmol) and tetrabutylammonium iodide (28 mg) and the mixture was stirred at 40 C. for 24 hr. Then, water (2 mL) was added to make the system homogeneous, which system was then analyzed by HPLC (conversion yield 89%). The aqueous solution was washed with toluene (0.5 mL), neutralized with hydrochloric acid to allow precipitation of a solid, and the solid was filtered and dried to give the objective N-Boc-(O-benzyl)tyrosine (312 mg, yield 84%). 1H-NMR (400 MHz, CDCl3)delta: 1.41(s, 3H), 2.86-3.13(m, 2 H), 4.53(m, 1H), 5.01(s, 2H), 6.35-7.41(m, 9H). 13C-NMR (100 MHz, CDCl3)delta: 176.51, 157.99, 136.99, 130.40, 128.58, 127.96, 127.48, 115.00, 80.32, 70.03, 36.93, 28.30. MS(ESI), m/z 370[M+-H] |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
67.9 mg (42%) | With N-ethyl-N,N-diisopropylamine; In N-methyl-acetamide; quinoclamine; water; | Part A Preparation of N-(6-(4-benzo[d]1,3-dioxolan-5-yl-6-phenyl(2-pyridyloxy))-2,2-dimethylhexyl)-2-((tert-butoxy)carbonylamino)-3-(4-hydroxyphenyl)propanamide 1-Amino-2,2-dimethyl-6-[(4-(3,4-methylenedioxyphenyl)-6-phenyl-2-pyridinyl)oxy]-hexane (0.100 g, 0.239 mmol) was dissolved in dimethylformamide (5 mL). Diisopropylethylamine (104.1 muL, 0.598 mmol) was added, and the reaction was stirred for 5 min. Boc-Tyr-OH (0.081 g, 0.287 mmol) and 2(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (0.100 g, 0.263 mmol) were added, and the reaction was stirred under nitrogen for 24 h. The reaction was concentrated to an oil under high vacuum. The oil was dissolved in 50:50 ACN/H2O and lyophilized. The crude product was then purified by preparative HPLC Method 2 to give 67.9 mg (42%) of product. ESMS: Calcd. For C40H47N3O7, 681.34; Found, 680.3 [M-H]-1HPLC Method 5. Rt=19.238 min Purity=98% |
67.9 mg (42%) | With N-ethyl-N,N-diisopropylamine; In N-methyl-acetamide; quinoclamine; water; | Part A Preparation of N-(6-(4-benzo[d]1,3-dioxolan-5-yl-6-phenyl(2-pyridyloxy))-2,2-dimethylhexyl)-2-((tert-butoxy)carbonylamino)-3-(4-hydroxyphenyl)propanamide 1-Amino-2,2-dimethyl-6-[(4-(3,4-methylenedioxyphenyl)-6-phenyl-2-pyridinyl)oxy]-hexane (0.100 g, 0.239 mmol) was dissolved in dimethylformamide (5 mL). Diisopropylethylamine (104.1 muL, 0.598 mmol) was added, and the reaction was stirred for 5 min. Boc-Tyr-OH (0.081 g, 0.287 mmol) and 2(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (0.100 g, 0.263 mmol) were added, and the reaction was stirred under nitrogen for 24 h. The reaction was concentrated to an oil under high vacuum. The oil was dissolved in 50:50 ACN/H2O and lyophilized. The crude product was then purified by preparative HPLC Method 2 to give 67.9 mg (42%) of product. ESMS: Calcd. for C40H47N3O7, 681.34; Found, 680.3 [M-H]-1 |
67.9 mg (42%) | With N-ethyl-N,N-diisopropylamine; In N-methyl-acetamide; quinoclamine; water; | Part A Preparation of N-(6-(4-benzo[d]1,3-dioxolan-5-yl-6-phenyl(2-pyridyloxy))-2,2-dimethylhexyl)-2-((tert-butoxy)carbonylamino)-3-(4-hydroxyphenyl)propanamide 1-Amino-2,2-dimethyl-6-[(4-(3,4-methylenedioxyphenyl)-6-phenyl-2-pyridinyl)oxy]-hexane (0.100 g, 0.239 mmol) was dissolved in dimethylformamide (5 mL). Diisopropylethylamine (104.1 muL, 0.598 mmol) was added, and the reaction was stirred for 5 min. Boc-Tyr-OH (0.081 g, 0.287 mmol) and 2(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (0.100 g, 0.263 mmol) were added, and the reaction was stirred under nitrogen for 24 h. The reaction was concentrated to an oil under high vacuum. The oil was dissolved in 50:50 ACN/H2O and lyophilized. The crude product was then purified by preparative HPLC Method 2 to give 67.9 mg (42%) of product. ESMS: Calcd. for C40H47N3O7, 681.34; Found, 680.3 [M-H]-1 HPLC Method 5. Rt=19.238 min Purity=98% |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With hydrogenchloride; In sodium hydroxide; hexane; ethyl acetate; | Example 2 N-tert-Butoxycarbonyl-O-ethyl-L-tyrosine (III) N-t-butoxycarbonyl-L-tyrosine (II, EXAMPLE 1, (235 g, 835 mmol) is dissolved in sodium hydroxide (4N, 705 mL) at 20-25. Diethyl sulfate (210 mL, 1.60 mol) is added over 15-20 min. The reaction mixture is stirred for 2 hr, then it is cooled with ice-bath (internal temperature around 15). Ethyl acetate (1400 mL) is added, followed by slow addition of hydrochloric acid (3N, 1410 mL) for 1 hr. The ethyl acetate layer is separated, and the aqueous layer is extracted with ethyl acetate (1400 mL). The ethyl acetate phase is concentrated to about 200 mL, then hexane (1600 mL) is added. The mixture is stirred in an ice-bath for 2 hr. filtered, washed with hexane (800 mL) in 3 portions. The precipitate is dried to give the title compound. The filtrate is concentrated, suspended in ethyl acetate/hexane (80/450 mL) for 2 hr, filtered and washed with hexane (250 mL) in 3 portions and dried to give additional title compound, NMR (MeOH-d4) delta 7.11, 6.80, 4.22, 4.05, 3.08, 2.86 and 1.36; CMR delta 175.4, 159.3, 157.8, 131.3, 130.4, 115.4, 80.5, 64.4, 56.4, 37.9, 28.7 and 15.2. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
88% | With acetic acid; In dichloromethane; ethyl acetate; | Step A. Preparation of N-[Nalpha-(tert-Butoxycarbonyl)-L-tyrosyl]-3,4-dihydroxybenzylamine Commercially available Nalpha-(tert-butoxycarbonyl)-L-tyrosine (1.5 g, 5.34 mmol) was coupled with <strong>[16290-26-9]3,4-dihydroxybenzylamine hydrobromide</strong> (1.76 g, 8.0 mmol) as described in general procedure F. The crude material was purified by flash chromatography using initially 30% then 60% EtOAc/CH2Cl2 containing 1% AcOH. The product was obtained as white powder (1.9 g, 88%). 1H NMR (DMSO-d6): 1.3 (s, 9H), 2.5-2.8 (m, 2H), 4.1 (t, J=4.5, 2H), 6.4-7.0 (m, 7H), 8.2 (s, 1H), 8.7 (br s, 2H), 9.0 (s, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
62.06 g (99%) | With N-ethyl-N,N-diisopropylamine; In dichloromethane; | EXAMPLE 2 Preparation of t-Butyloxycarbonyl-tyrosyl-(N-epsilon-benzyloxycarbonyl)lysine benzyl ester 3 A suspension of lysine derivative 2 (40.65 g, 100 mmol) in CH2 Cl2 (350 mL) was treated with diisopropylethylamine (17.5 mL, 100 mmol) and the resulting solution was cooled to 0 C. N-t-Butyloxycarbonyl tyrosine (Vega, 28.10 g, 100 mmol) was added in one portion, followed by 1-ethyl-3-(3-dimethylaminopropyl)carbondiimide (Sigma, 21.09 g, 100 mmol). The resulting suspension cleared to a homogeneous solution upon stirring at 0 C. After 18 h, the reaction solution was washed with saturated NaHCO3, then 1N HCl, and dried (MgSO4) and concentrated to give 62.06 g (99%) of a white solid. Recrystallization from hot ethanol/water returns 90.2%: Purity 99.7% (HPLC, System A); MP 68-70 C.; 1 H NMR (DMSO-d6) delta1.28 (s, 9H), 1.33 (m, 4H), 1.67 (m, 2H), 2.54 (m, 1H), 2.79 (m, 1H), 2.94 (m, 2H), 4.10 (m, 1H), 4.28 (m, 1H), 4.98 (s, 2H), 5.10 (s, 1H), 6.62 (d, J=8.4 Hz, 2H), 6.77 (d, J=8.6 Hz, 1H, exchangeable with D2 O), 7.02 (d, J=8.4 Hz, 2H), 7.20 (m, 1H, exchangeable with D2 O), 7.33 (m, 10H), 8.24 (d, J=7.8 Hz, exchangeable with D2 O), 9.12 (s, 1H, exchangeable with D2 O); 13 C NMR (DMSO-d6) delta 22.4, 27.9, 28.8, 30.4, 36.8, 42.1, 43.2, 52.0, 53.5, 65.1, 65.8, 78.1, 115.0, 127.7, 127.8, 127.9, 128.1, 128.4, 128.5, 130.2, 136.1, 137.5, 156.1, 156.3, 169.2, 171.6, 171.9; FAB+ MS m/z 534.5 (M+H - Me3 CO2 C). Anal. Calcd for C35 H3 N3 O8 H2 O: C, 64.50; H, 6.91; N, 6.76. Found: C, 64.50; H, 6.95; N, 6.56. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With tetra-(n-butyl)ammonium iodide; In N,N-dimethyl-formamide; | (A) (2S)-3-[4-(Benzyloxy)phenyl]-2-amino-N-Boc-propanol (Compound 48) To a stirred solution of N-Boc-L-tyrosine (Compound 46; 4.0 gr, 14.2 mmol) in DMF (20 mL) at room temperature was added benzyl bromide (3.7 mL, 30.6 mmol), Cs2 CO3 (13.9 gr, 42.6 mmol) and TBAI (25 mg, 0.07 mmol). Stirring was continued for 24 hours after which the reaction was taken up in EA (100 mL). The organic layer was washed with 1N HCl (3*20 mL), saturated NaHCO3 (3*20 mL) and saturated NaCl (1*20 mL). The organic layer was dried (MgSO4) and concentrated to give a crude yellow solid. Purification by flash chromatography (EA:H;1:4) afforded O-benzyl-L-tyrosine-N-Boc-benzyl ester (Compound 47) as a white solid (3.0 gr, 46 percent). 1 H NMR (500 MHz, CDCl3) delta1.42 (s, 9 H), 3.0 (d, 2H, J=3.1 Hz), 4.58 (q, 1H, J=5.8 Hz), 4.97 (q, 1H, J=8.3 Hz), 5.0 (s, 2H), 5.15 (q, 2H, J=12.3 Hz), 6.9 (AB, 4H, J=8.4, 53.5 Hz), 7.29-7.43 (m, 5H) ppm; 13 C NMR (125 MHz, CDCl3) delta28.3, 37.3, 54.5, 67.0, 69.9, 79.9, 114.8, 127.4, 127.9, 128.4, 128.5, 130.3, 135.0, 136.9, 155.1, 157.8, 171.7 ppm. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
87.8% | With dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 24h; | |
74.87% | With benzotriazol-1-ol; dicyclohexyl-carbodiimide In dichloromethane at 20℃; Cooling with ice; | |
4.56 g | With benzotriazol-1-ol; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 48h; Cooling with ice; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
88.8% | With dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 24h; | |
84% | With triethylamine; dicyclohexyl-carbodiimide In N,N-dimethyl-formamide; acetonitrile at 20℃; for 3h; Cooling with ice; Inert atmosphere; | 5 4.5 .Nα-(tert-butoxycarbonyl)-l-tyrosyl-l-tyrosine (3) To a mixture of 5 (0.7 g, 3.55 mmol) and 6 (1 g, 3.55 mmol) in CH3CN/DMF (40 mL/10 mL), triethylamine (0.48 mL, 3.6 mmol) was added while the reaction vessel was cooled on an ice bath. DCC (0.95 g, 4.6 mmol) was subsequently added and the reaction mixture was allowed to stir at room temperature for 3 h. The precipitated DCU was removed by filtration and the solvent from the filtrate was evaporated. The residue was partitioned between EtOAc (100 mL) and 1 M HCl (100 mL). The aqueous phase was extracted with EtOAc (3 * 100 mL). The combined organic fractions were washed with saturated NaHCO3 (100 mL), brine (100 mL), and dried (MgSO4). The solvent was removed under reduced pressure and the residue was purified by flash chromatography (2:1 EtOAc:hexane) to afford Boc-Tyr-Tyr-OMe as a white solid (1.3 g, 3.0 mmol, 84%). 1H NMR (300 MHz, CDCl3): δ 7.37 (br, 2 H), 6.91 (d, J = 8.0 Hz, 2H), 6.80 (d, J = 8.0 Hz, 2H), 6.68 (d, J = 8.0 Hz, 4H), 6.55 (1H, buried amide NH), 5.27 (br, 1H), 4.72 (m, 1H), 4.29 (m, 1H), 3.64 (s, 3H), 2.96-2.89 (m, 4H), 1.40 (s, 9H). |
80% | With benzotriazol-1-ol; dicyclohexyl-carbodiimide In ethyl acetate; N,N-dimethyl-formamide at 20℃; for 24h; |
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine at 20℃; Inert atmosphere; | ||
Stage #1: L-Tyr-OMe; Boc-Tyr-OH With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate In N,N-dimethyl-formamide for 0.25h; Inert atmosphere; Stage #2: With triethylamine In N,N-dimethyl-formamide at 0℃; for 18.25h; Inert atmosphere; | 5.1 Step 1: Preparation of (S)-methyl 2-((R)-2-((tert-butoxycarbonyl)amino)-3-(4-hydroxyphenyl) propanamido)-3-(4-hydroxyphenyl)propanoate A 1L reactor equipped with a magnetic stirrer, temperature probe, and nitrogen inlet was charged with ((S)-2-((tert-butoxycarbonyl)amino)-3-(4-hydroxyphenyl)propanoic acid (33.2 g, 118 mmol), (S)-methyl 2-amino-3-(4- hydroxyphenyl)propanoate (20 g, 102 mmol), hexafluorophosphate benzotriazole tetramethyl uronium (“HBTU,” 48.3 g, 127 mmol) and DMF (120 mL). The solution was stirred for 15 minutes and then cooled to 0°C. Triethylamine (42.6 mL, 306 mmol) was added to the mixture over 15 minutes. After the addition was completed, the cooling bath was removed, and the reaction was stirred overnight. After 18 h, the HPLC of the aliquot showed complete conversion of the starting materials. One hundred mL of water was slowly added to the reaction at 0°C. After stirring for 30 minutes (min), the mixture was diluted with EtOAc (150 mL), and the layers were separated. The organic layer was washed with aqueous sodium carbonate (10%, 3 x 50 mL) and finally with brine (50 mL). The organic layer was then dried over anhydrous sodium sulfate, filtered, and concentrated to dryness to afford the desired product as a thick oil. The product was used in the next step without further purification. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
68% | Stage #1: Boc-Tyr-OH With potassium <i>tert</i>-butylate In dimethyl sulfoxide for 0.25h; Inert atmosphere; Stage #2: 4-chloroquinoline In dimethyl sulfoxide at 30℃; for 144h; Inert atmosphere; Stage #3: With citric acid In diethyl ether; water; dimethyl sulfoxide | 109.a Example 109; 2-{(S)-1-Carboxy-2-[4-(quinolin-4-yloxy)-phenyl]-ethylamino}-6-chloro- quinoline-3-carboxylic acid; a) (S)-3-[4-(quinolin-4-yloxy)-phenyl]-2-tert-butoxycarbonylamino- propionic acid; [00222] N-Soc-L-Tyrosine (0.844 g, 3 mmol) and KOBu-t (0.727 g, 6.5 mmol) are dissolved in dry DMSO (2.9 ml.) under argon atmosphere in a tightly closed glass reaction tube and stirred for 15 min, then 4- chloroquinotine (0.491 g, 3 mmol) is added. The mixture is stirred for 6 days at 30 0C. When only traces of 5-bromo-2-chloropyridine are detected (LC- MS control), the reaction mixture is poured into water (40 ml.) and the aqueous phase is washed with diethyl ether (2x20 mL). The pH of aqueous phase is adjusted to ~4 by adding 20% aqueous citric acid. The product precipitated is collected on filter and washed with water (50 mL) to give the title compound (0.833 g, 68%) as a grey solid. LC-MS: 437.4 [M+H]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With 1-hydroxy-pyrrolidine-2,5-dione; sodium hydrogencarbonate; dicyclohexyl-carbodiimide In tetrahydrofuran; water at 0 - 20℃; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
General procedure: The p-nitrophenoxycarbonyl derivative of Boc-1,2-diaminoethane was obtained as described earlier [19]. This compoundwas coupled to the MBHA resin (0.75 meq./g, 1% crosslink, 100-200 mesh, 6 eq.) in DMF at 60 C for 48 h to afford Boc-NH-CH2-CH2-NH-CO-MBHA-resin. The Boc group was removed by treatment with 15% HCl/dioxane (5 and 15 min), resin was neutralized with DIPEA, then protected amino acids were successively attached in the required sequence, by dividing resin into smaller portions, and using TBTU/HOBt methodology (3 fold excess of coupling reagent). Completeness of couplings was monitored by Kaiser test. The protected peptide resins were treated with 55% piperidine in DMF with stirring for 50 min to remove Fmoc groups. To the suspension of each resin in 350 mL DMF (for 1 mmol scale) containing DIPEA (1.2-1.3 eq.) the solution of bis(p-nitrophenyl)carbonate (1.2-1.3 eq.) in 150 mL DMF was added during 4 h. The reaction was allowed to continue until free amino groups could no longer be detected on the resin (5-7 days), then the solvent was removed under reduced pressure. The peptides were cleaved fromthe resin by treatment with TFA/cocktail (TFA:phenol:water, 13.5:1:1, mL/g/g) for 10 min at 5 C, and 3 h at RT under argon. The resin was filtered off, washed with TFA, AcOH and DCM. Filtrate and washings were combined, evaporated to oily residue. This residue was dissolved in AcOH and dropped into 200 mL of stirred MTBE. After cooling in the refrigerator; fluffy precipitate was filtered and dried under reduced pressure over KOH pellets. Starting from 0.88 mmol of substituted resin ca. 400 mg of crude peptide was obtained. In case of peptides 11-14 TFA:TFMSA:tioanisole:ethandithiole (10:1:1:0.5 mL) mixture was used to cleave the peptides from the resin. All crude analogues synthesized by the SPPS method were subjected to two-steps purification, first by flash column chromatographyor by preparative TLC, and final purification which was accomplished by semi-preparative RP-HPLC in conditions described above. Homogeneity of the purified analogues was assessed by TLC and analytical HPLC. Analytical data of the peptides are presented in Table 1. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
General procedure: The p-nitrophenoxycarbonyl derivative of Boc-1,2-diaminoethane was obtained as described earlier [19]. This compoundwas coupled to the MBHA resin (0.75 meq./g, 1% crosslink, 100-200 mesh, 6 eq.) in DMF at 60 C for 48 h to afford Boc-NH-CH2-CH2-NH-CO-MBHA-resin. The Boc group was removed by treatment with 15% HCl/dioxane (5 and 15 min), resin was neutralized with DIPEA, then protected amino acids were successively attached in the required sequence, by dividing resin into smaller portions, and using TBTU/HOBt methodology (3 fold excess of coupling reagent). Completeness of couplings was monitored by Kaiser test. The protected peptide resins were treated with 55% piperidine in DMF with stirring for 50 min to remove Fmoc groups. To the suspension of each resin in 350 mL DMF (for 1 mmol scale) containing DIPEA (1.2-1.3 eq.) the solution of bis(p-nitrophenyl)carbonate (1.2-1.3 eq.) in 150 mL DMF was added during 4 h. The reaction was allowed to continue until free amino groups could no longer be detected on the resin (5-7 days), then the solvent was removed under reduced pressure. The peptides were cleaved fromthe resin by treatment with TFA/cocktail (TFA:phenol:water, 13.5:1:1, mL/g/g) for 10 min at 5 C, and 3 h at RT under argon. The resin was filtered off, washed with TFA, AcOH and DCM. Filtrate and washings were combined, evaporated to oily residue. This residue was dissolved in AcOH and dropped into 200 mL of stirred MTBE. After cooling in the refrigerator; fluffy precipitate was filtered and dried under reduced pressure over KOH pellets. Starting from 0.88 mmol of substituted resin ca. 400 mg of crude peptide was obtained. In case of peptides 11-14 TFA:TFMSA:tioanisole:ethandithiole (10:1:1:0.5 mL) mixture was used to cleave the peptides from the resin. All crude analogues synthesized by the SPPS method were subjected to two-steps purification, first by flash column chromatographyor by preparative TLC, and final purification which was accomplished by semi-preparative RP-HPLC in conditions described above. Homogeneity of the purified analogues was assessed by TLC and analytical HPLC. Analytical data of the peptides are presented in Table 1. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
General procedure: The p-nitrophenoxycarbonyl derivative of Boc-1,2-diaminoethane was obtained as described earlier [19]. This compoundwas coupled to the MBHA resin (0.75 meq./g, 1% crosslink, 100-200 mesh, 6 eq.) in DMF at 60 C for 48 h to afford Boc-NH-CH2-CH2-NH-CO-MBHA-resin. The Boc group was removed by treatment with 15% HCl/dioxane (5 and 15 min), resin was neutralized with DIPEA, then protected amino acids were successively attached in the required sequence, by dividing resin into smaller portions, and using TBTU/HOBt methodology (3 fold excess of coupling reagent). Completeness of couplings was monitored by Kaiser test. The protected peptide resins were treated with 55% piperidine in DMF with stirring for 50 min to remove Fmoc groups. To the suspension of each resin in 350 mL DMF (for 1 mmol scale) containing DIPEA (1.2-1.3 eq.) the solution of bis(p-nitrophenyl)carbonate (1.2-1.3 eq.) in 150 mL DMF was added during 4 h. The reaction was allowed to continue until free amino groups could no longer be detected on the resin (5-7 days), then the solvent was removed under reduced pressure. The peptides were cleaved fromthe resin by treatment with TFA/cocktail (TFA:phenol:water, 13.5:1:1, mL/g/g) for 10 min at 5 C, and 3 h at RT under argon. The resin was filtered off, washed with TFA, AcOH and DCM. Filtrate and washings were combined, evaporated to oily residue. This residue was dissolved in AcOH and dropped into 200 mL of stirred MTBE. After cooling in the refrigerator; fluffy precipitate was filtered and dried under reduced pressure over KOH pellets. Starting from 0.88 mmol of substituted resin ca. 400 mg of crude peptide was obtained. In case of peptides 11-14 TFA:TFMSA:tioanisole:ethandithiole (10:1:1:0.5 mL) mixture was used to cleave the peptides from the resin. All crude analogues synthesized by the SPPS method were subjected to two-steps purification, first by flash column chromatographyor by preparative TLC, and final purification which was accomplished by semi-preparative RP-HPLC in conditions described above. Homogeneity of the purified analogues was assessed by TLC and analytical HPLC. Analytical data of the peptides are presented in Table 1. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
General procedure: The p-nitrophenoxycarbonyl derivative of Boc-1,2-diaminoethane was obtained as described earlier [19]. This compoundwas coupled to the MBHA resin (0.75 meq./g, 1% crosslink, 100-200 mesh, 6 eq.) in DMF at 60 C for 48 h to afford Boc-NH-CH2-CH2-NH-CO-MBHA-resin. The Boc group was removed by treatment with 15% HCl/dioxane (5 and 15 min), resin was neutralized with DIPEA, then protected amino acids were successively attached in the required sequence, by dividing resin into smaller portions, and using TBTU/HOBt methodology (3 fold excess of coupling reagent). Completeness of couplings was monitored by Kaiser test. The protected peptide resins were treated with 55% piperidine in DMF with stirring for 50 min to remove Fmoc groups. To the suspension of each resin in 350 mL DMF (for 1 mmol scale) containing DIPEA (1.2-1.3 eq.) the solution of bis(p-nitrophenyl)carbonate (1.2-1.3 eq.) in 150 mL DMF was added during 4 h. The reaction was allowed to continue until free amino groups could no longer be detected on the resin (5-7 days), then the solvent was removed under reduced pressure. The peptides were cleaved fromthe resin by treatment with TFA/cocktail (TFA:phenol:water, 13.5:1:1, mL/g/g) for 10 min at 5 C, and 3 h at RT under argon. The resin was filtered off, washed with TFA, AcOH and DCM. Filtrate and washings were combined, evaporated to oily residue. This residue was dissolved in AcOH and dropped into 200 mL of stirred MTBE. After cooling in the refrigerator; fluffy precipitate was filtered and dried under reduced pressure over KOH pellets. Starting from 0.88 mmol of substituted resin ca. 400 mg of crude peptide was obtained. In case of peptides 11-14 TFA:TFMSA:tioanisole:ethandithiole (10:1:1:0.5 mL) mixture was used to cleave the peptides from the resin. All crude analogues synthesized by the SPPS method were subjected to two-steps purification, first by flash column chromatographyor by preparative TLC, and final purification which was accomplished by semi-preparative RP-HPLC in conditions described above. Homogeneity of the purified analogues was assessed by TLC and analytical HPLC. Analytical data of the peptides are presented in Table 1. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
50% | With hydrogenchloride; benzotriazol-1-ol; N-ethyl-N,N-diisopropylamine; dicyclohexyl-carbodiimide In ethanol; water |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 0 - 20℃; | General procedure: EDC hydrochloride (1.1 equiv) and HOBt (1.2 equiv) were added to the solution of N-BocXaaOH (Xaa=Gln, Glu(OMe), Lys(N-Cbz), 1.0 equiv), TsOH salt of ValOBn (1.0 equiv), and i-Pr2NEt (1.1 equiv) in DMF at 0C. The mixture was stirred for 2h at 0C and overnight at room temperature, and concentrated in vacuo. The residue was dissolved in CH2Cl2, and washed with 4% NaHCO3, 1M HCl, and water. The organic layer was dried over Na2SO4 and concentrated in vacuo giving a residue that was subjected to silica gel column chromatography using hexane/AcOEt or CH2Cl2/MeOH as eluents to give the desired protected dipeptide N-BocXaaValOBn (65-87%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
64% | With triethylamine; dicyclohexyl-carbodiimide; In N,N-dimethyl-formamide; acetonitrile; at 0℃; for 7h; | A solution of LDOPAmethyl ester hydrochloride 2 (0.27 g, 1.11 mmol) andN-(tert-butoxycarbonyl)-L-tyrosine (0.33 g, 1.16 mmol) inDMF (2.2 mL) and acetonitrile (9 mL) was cooled in ice.With stirring, triethylamine (0.16 mL, 1.11 mmol) was addedfollowed by dicyclohexylcarbodiimide (0.25 g, 1.11 mmol).After 7 h of continued stirring at 0 C, the reaction mixturewas cooled in the freezer overnight. The insoluble materialwas filtered off and washed with ethyl acetate. The combinedfiltrate was evaporated and the residue was dissolvedin ethyl acetate (40 mL) and water (25 mL). The organiclayer was washed successively with 25 mL portions of 0.5 NHCl, H2O, 0.5 N NaHCO3 and brine and dried over MgSO4.After filtration and concentration, the crude yellow solid wassubjected to silica chromatography (ethyl acetate/hexane =1:1, then 3:1) to afford a colorless amorphous mass (0.34 g,64%) 1H NMR (CD3OD): 1.34 (s, 3H), 2.67 (m, 1H), 2.90(m, 3H), 3.35 (s, 3H), 3.66 (s, 3H), 4.23 (t, J = 6.9 Hz, 1H),4.59 (t, J = 6.8 Hz, 1H), 6.48 (d, J = 7.9 Hz, 1H), 6.62 (s,1H), 6.68 (d, J = 7.9 Hz, 1H), 6.69 (d, J = 8.6 Hz, 2H), 7.01(d, J = 8.6 Hz, 2H); 13C NMR (CD3OD): 28.6, 37.9, 38.4,52.6, 55.2, 57.5, 80.7, 116.1. 116.3, 117.2, 121.7, 129.0,129.1, 131.3, 145.3, 146.2, 157.1, 157.5, 173.2, 174.2;HRMS (ESI): calcd. for C24H31N2O8 (M++H) 475.2080,found 475.2055; []D -2.1 (c 2.0, CH3OH). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With benzotriazol-1-ol; dicyclohexyl-carbodiimide In N,N-dimethyl-formamide at 0℃; | (S)-2-Amino-N-(2-(7-chloroquinolin-4-ylamino) ethyl)-3-hydroxypropanamide (13) General procedure: (S)-2-Amino-N-(2-(7-chloroquinolin-4-ylamino) ethyl)-3-hydroxypropanamide (13) Gummy residue (1-hydroxybenzotriazoleHOBt (1.1 equiv.) and N,N0-dicyclohexylcarbodiimideDCC (1.5 equiv.) are added successively to asuspension of (S)-2-(tert-butoxycarbonylamino)-3-hydroxypropanoicacid (1 equiv.) in 15 mL of DMF. The mixturewas left under stirring for 30 min before adding N'-(7-chloroquinolin-4-yl) ethane-1,2-diamine, the stirring wascontinued for 4-6 h at 0° C temperature. The reactionmedium is then diluted with 40 mL of ethyl acetate andthen filtered, and washed with 40 mL of water saturatedwith NaCl. The organic phase is dried over Na2SO4, filteredand then evaporated. The crude product obtained ispurified by Column chromatography on silica gel (230-400mesh eluent: dichloromethane/Methanol 9:1). The fractionscontaining the desired compound according to TLCrevealed under UV are pooled and evaporated. The quantitativeyields were obtained for desired intermediates.Further Boc deprotection was done by TFA/DCM at roomtemperature for 4-6 h which leads to desired product ingood yield. It was obtained as gummy substance in 76 %yield); |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
78% | With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In dichloromethane; at 20℃; for 24h; | To a suspension of Boc-(L)-tyrosine (commercially available) (9.4 mmol, 2.64 g) 1in DCM (60 ml) were added N-hydroxybenzotriazole (HOBt) hydrate (14.1 mmol, 1.91 g)and corresponding amine (10 mmol) 2. The reaction mixture was cooled to 0 - 5 C before 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) hydrochloride (11.8 mmol, 2.25 g)was added. The reaction mixture was stirred at room temperature for 24 h. An additional 70ml of DCM was added, and the organic layer was washed consecutively with 1.6 M citricacid (25 ml), saturated NaHCO3 (25 ml), and saturated NaC1 (40 ml) aqueous solution. Theorganic phase was dried over Na2SO4 and concentrated under vacuum. Obtained crudeproduct was purified by silica gel column chromatography to give product 3. Yield 78%. ?H NMR (400 IVIFIz, CDC13): 7.04-7.01 (m, 2H, aromatic), 6.70-6.77(m, 2H, aromatic), 5.46-5.30 (m, J= 14.4 Hz, 2H, CH=CH), 4.16-4.13 (m, 1H, CI{NH2),3.17-3.14 (m, 2H, CH2CH2NH), 2.93-2.88 (dd,J= 13.8, 6.1 Hz, 1H, CHaHb(Tyr)), 2.75-2.70(dd, J 13.8, 6.1 Hz, 1H, CHaHb(Tyr)), 1.97-1.95 (m, 4H, CH2CH=CHCH2), 1.38-1.28 (m,33H, Boc, 12CH2), 0.91-0.88 (m, 3H, CH3CH2). LR-MS: m/z calcd 529.4011 (M-H), found529.59 (M-H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
34% | With potassium carbonate; In N,N-dimethyl-formamide; at 20℃; | General procedure: L - tyrosine (2.8 g, 10 mmol) was dissolved in 50 mL DMF, then K2CO3(4.15 g, 30 mmol) and iodomethane (1.37 mL, 22 mmol) were added in a row. Stirred at room temperature till the reactant was run out, detected by TLC. Then, 150 mL water was added into the solution and extracted with EtOAc. After dried by MgSO4 and concentrated, the obtained oil was dissolved in 30 mL methanol and NaOH (1.3 mmol/mL) was added. After stirred for 5 h, the solution was neutralized by 1M HCl solution and extracted with EtOAc. 0.5M citric acid and brine were used to wash the organic phase, and concentrated to colorless oil. Finally, purification by column chromatography (PE/EA=10: 3) to generate compound 6a, colorless oil. Yield: 13%. 1H NMR (400 MHz,Chloroform-d) delta 7.12 (d, J=8.2 Hz, 2H), 6.87 (d, J=8.4 Hz, 2H), 4.68- 4.49 (m, 1H), 3.81 (s, 3H), 3.11 (ddd, J=34.8, 13.6, 5.3 Hz, 2H),1.45 (s, 9H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
General procedure: The EMs and new EM analogs were synthesized by a solid phase synthesis strategy at 0.6 mmol on a Rink amide resin, as described previously. Briefly, Fmoc-(2-furyl)Map/Phe-OH (3 equiv) was coupled with a resin in the presence of coupling reagents. After the removal of 9-fluorenylmethyl (Fmoc), Fmoc-Trp(Boc)/Phe-OH, Fmoc-Xaa-OH, and Boc-Tyr-OH were sequentially coupled under the same reaction conditions. DIPEA (6 equiv)/HBTU (3 equiv)/HOBt (3 equiv) were used as the coupling reagents. The Fmoc-protecting group was remove dusing 3% DBU + 3% piperidine in dimethylformamide. The mixture (2.5% H2O, 2.5% TIPS and 95% TFA) was used to cleave the peptides from the resin for 3 h. When the reaction was completed, the reagent was concentrated and pre-cooled at -20 C. Thereafter, the residue was extracted with water/diethyl ether. After the aqueous phase was collected and lyophilized, the crude peptides were obtained as white solids (yields 50-70%). |
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :